Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be cleared from shelves as the FDA has proposed to discontinue the sale of products ...
A common cold medicine has been deemed ineffective and will no longer be available for purchase. The Food and Drug Administration announced Wednesday its intention to remove oral phenylephrine, a ...
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After ...
A pharmaceutical ingredient that’s been a key component in nasal decongestants for decades is having its efficacy called into question, and the FDA is now weighing whether to change the compound’s ...
The FDA orders the recall of a nasal spray in the US after finding live microbes; immunocompromised patients are at greatest ...
For a second year, members of the Senate Health Committee advanced a bill Thursday to allow pharmacists to sell ivermectin, a ...
Advisers for the US Food and Drug Administration voted unanimously on Wednesday in support of making the birth-control pill Opill available over-the-counter, saying the benefits outweigh the risks.
PHILADELPHIA, January 07, 2026--iECURE Receives FDA Regenerative Medicine Advanced Therapy Designation for ECUR-506 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback